E
Elio Agostoni
Researcher at University of Milano-Bicocca
Publications - 129
Citations - 1882
Elio Agostoni is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Stroke & Migraine. The author has an hindex of 21, co-authored 114 publications receiving 1458 citations. Previous affiliations of Elio Agostoni include University of Milan.
Papers
More filters
Journal ArticleDOI
Depression after Stroke and Risk of Mortality: A Systematic Review and Meta-Analysis
Francesco Bartoli,Nicoletta Lillia,A Lax,Cristina Crocamo,Mantero,Giuseppe Carrà,Elio Agostoni,Massimo Clerici +7 more
TL;DR: The potential role of depression on post stroke mortality is confirmed, and the relationship between depression and mortality after stroke seems to be related to the followup duration.
Journal ArticleDOI
Current and emerging evidence-based treatment options in chronic migraine: a narrative review
Elio Agostoni,Piero Barbanti,Paolo Calabresi,Bruno Colombo,Pietro Cortelli,Fabio Frediani,Pietrangelo Geppetti,Licia Grazzi,Massimo Leone,Paolo Martelletti,Luigi Alberto Pini,Maria Pia Prudenzano,Paola Sarchielli,Gioacchino Tedeschi,Antonio Russo +14 more
TL;DR: The future of chronic migraine management in relation to recent progress in evidence-based pharmacological treatment is discussed and new developments in this field have the potential to improve the diagnosis and provide more individualised treatments for this condition.
Journal ArticleDOI
Headache in cerebral venous thrombosis.
TL;DR: It is concluded that these headache features, especially in the presence of underlying prothrombotic conditions, should lead clinicians to consider the diagnosis of CVT and to require appropriate neuroimaging examinations.
Journal ArticleDOI
Prehospital stroke scales and large vessel occlusion: A systematic review.
Simone Vidale,Elio Agostoni +1 more
TL;DR: Aim of this analysis was to determine the diagnostic accuracy of prehospital stroke scales detecting LVO.
Journal ArticleDOI
European consensus conference on unruptured brain AVMs treatment (Supported by EANS, ESMINT, EGKS, and SINCH)
Marco Cenzato,Edoardo Boccardi,Ettore Beghi,Peter Vajkoczy,István Szikora,Enrico Motti,Luca Regli,Andreas Raabe,Shalva Sh Eliava,Andreas Gruber,Torstein R. Meling,Mika Niemelä,Alberto Pasqualin,Andrey Golanov,Bengt Karlsson,Andras A. Kemeny,Roman Liscak,Bodo Lippitz,Matthias W. R. Radatz,Alessandro La Camera,René Chapot,Civan Islak,Laurent Spelle,Alberto Debernardi,Elio Agostoni,Martina Revay,Michael K. Morgan +26 more
TL;DR: The panel made the following statements and general recommendations: Brain arteriovenous malformation (AVM) is a complex disease associated with potentially severe natural history, and the results of a randomized trial (ARUBA) cannot be applied equally for all unruptured brain arterIOvenousmalformation (uBAVM).